Skip to main content
. 2022 Jul 25;16:917867. doi: 10.3389/fnins.2022.917867

Figure 9.

Figure 9

Computed structural comparison and binding features (visualization using UCSF Chimera and AutoDock) of Chlorogenic acid (A), Ervacycline (B), Rolitetracycline (C), Tigecycline (D), Minocycline (E), and Naringenin (F) with Angiotensin-Converting Enzyme Receptor 2. The lower the binding energy, the greater will be the binding affinity.